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Abstract In G protein-coupled receptors, neurotransmitter-induced binding of GTP to G proteins triggers the activation of effector systems while 
simultaneously decreasing the affinity of the transmitter for its specific binding site within the receptor~G protein complex. In the present study we 
show that, in the chick optic tectum, guanine nucleotides inhibit the binding of the glutamate analog, kainate, and activate adenylate cyclase by 
different mechanisms and acting on different sites. GMP-PNP, a non-hydrolyzable analog of GTP, binds tightly to G proteins o that the binding 
is stable ven after exhaustive washing. By use of this property, we have prepared membrane samples in which G protein GTP-binding sites are 
pre-saturated with GMP-PNP. Experiments carried out with these membranes show that GMP-PNP, GDP-S and GMP inhibit the binding of 
[3H]kainate by interacting with site(s) unrelated to G proteins, whereas GMP-PNP activates adenylate cyclase activity by binding to G proteins. 
Key words: Kainic acid receptor; Guanine nucleotide; G protein; Adenylate cyclase; Chick optic tectum 
1. Introduction 
Cells receive much of their information through membrane- 
coupled signalling pathways that use GTP-binding proteins 
(G proteins) to transduce and convey signals from cell surface 
receptors to cellular effector proteins [1-4]. The interaction of 
agonists with some receptors triggers the binding of GTP to 
specific G proteins which, in turn, modulate the activities of 
specific effectors, while simultaneously decreasing the agonist- 
receptor binding affinity. Intrinsic GTPase activity hydrolyzes 
bound GTP to bound GDP, thereby inactivating the G pro- 
tein--effector system. 
This G protein-mediated inhibitory effect of GTP (or GDP) 
on agonist binding has been well demonstrated in many neuro- 
transmitter systems [1,2]. In contrast, there are results indicat- 
ing that guanine nucleotides may inhibit the binding of gluta- 
mate analogs [5-12] by mechanisms not involving G proteins. 
Glutamate is the major excitatory neurotransmitter in the 
CNS. Pharmacological nd molecular studies have established 
the existence of two major classes of glutamate receptors: ion- 
otropic receptors, which are ligand-gated ion channels, and 
metabotropic receptors, which are coupled to cellular effectors 
through G proteins. By using agonists and antagonists, gluta- 
mate receptors may be further differentiated into five subtypes: 
NMDA, KA, AMPA (which may overlap with the KA site), 
L-AP4 and trans-ACPD [13-15]. 
Well-known examples of effector proteins regulated by ag- 
onists through G proteins are adenylate cyclase (AC), cGMP 
phosphodiesterase, phospholipase C and ion channels [1-4]. 
Coupling between receptors and AC is mediated by two types 
of G proteins, namely Gs and Gi, which respectively activate or 
inhibit AC [2,4]. AC produces cAMP, a second messenger that 
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regulates the phosphorylation of cellular proteins, thereby 
modulating synaptic transmission and neural function [16-17]. 
In the present study, a direct comparison of the effects of 
guanine nucleotides on KA binding and on AC activity pro- 
vides further evidence to the effect that, in CNS membrane 
preparations, guanine nucleotides bind to KA-recognizing 
sites, as well as to G proteins. 
2. Materials and methods 
2.1. Animals 
White Leghorn young chicks (6-12 days old) were used (from AviArio 
Jari). They were kept at 37°C, on a 12-h light/12-h dark cycle. 
2.2. Materials 
Imido [8-3H]guanosine 5'-triphosphate (GMP-PNP, 19.1 Ci/mmol), 
[8-3H]guanosine 5'-diphosphate (GDP, 11.6 Ci/mmol), and [3H]kainic 
acid (KA, 58 Ci/mmol) were obtained from Amersham International, 
UK; protein kinase, for cAMP determinations, guanylyl-imi- 
dodiphosphate (GMP-PNP), GTP, GDP-S, GMP and ATP were from 
Sigma or Boehringer-Mannheim. All other chemicals of analytical 
grade were obtained from standard commercial suppliers. 
2.3. Membrane preparations 
Preparations were carried out as described in [10]. Optic tectal lobes 
were homogenized in 0.32 M sucrose prepared in 10 mM Tris-HCl 
buffer, pH 7.4, containing 1mM MgC12. The homogenate was centri- 
fuged at 1,000 xg for 10 min, and the pellet resuspended and centri- 
fuged again. The second pellet was discarded and the supernatants 
pooled and centrifuged at 27,000 xg for 20 min. The resulting pellet was 
lysed in 1 mM Tris-HC1 buffer, pH 7.4, for 30 min, and centrifuged at 
27,000 xg for 20 min. This pellet was washed three times in lysis buffer, 
at 27,000 x g for 20 rain. To pre-saturate, and thus block, GTP-binding 
sites in G proteins the final pellet was preincubated in 50 mM Tris-HCl 
buffer, pH 7.4, 10 mM MgC12, 1 mM DTT, together with 10/zM 
GMP-PNP (or with variable [3H]GMP-PNP concentrations to monitor 
the saturation process - see below), at 30"C for 15 min. In all these 
experiments, control membrane preparations were preincubated in the 
same buffer, under the same experimental conditions, without GMP- 
PNP. Then, the membranes were kept at 4°C for 15 rain, centrifuged 
at 27,000 xg for 20 min, and washed three times with preincubation 
buffer (without GMP-PNP) to remove unbound and labile, bound 
GMP-PNP. The final pellet was diluted in the same buffer and used for 
determination f [3H]KA and [3H]guanine ucleotide binding, and of 
AC activity. 
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2.4. Binding assays 
Binding assays of [3H]GMP-PNP, [3H]GDP or [3H]KA were per- 
formed at 30°C in small polycarbonate ubes (total volume 1 ml), 
containing 50 mM Tris-HCl, pH 7.4, 10 mM MgCI2, 1 mM DTT, 
0.5 mg membrane protein, and the radioactive ligand, with or without 
the displacer (non-radioactive ligand). Incubation was started by addi- 
tion of membrane and stopped after 5 min ([3H]GDP), or after 15 min 
([3H]GMP-PNP and [3H]KA) by centrifugation at15,000 x g, for 2 min 
([3H]GDP and [3H]GMP-PNP), or at 27,000 × g for 30 min ([3H]KA) 
[10]. The supernatant was discarded and the walls of the tubes and the 
surface of the pellets were quickly and carefully rinsed with cold dis- 
tilled water. The pellets were processed for radioactivity and protein 
measurement. In binding experiments using radioactive GMP-PNP 
during preincubation (monitoring of pre-saturation experiments - see 
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Fig. 1. Saturation curve of [3H]GMP-PNP binding to chick optic tectum 
membranes under the conditions used in preincubation experiments 
with tritiated or non-radioactive GMP-PNP. Preincubation was carried 
out at 30°C. After that, membranes were washed 3 times, as indicated 
in section 2, and processed to measure bound [3H]GMP-PNP. (A) 
Saturation curve of specific binding. (B) Scatchard analysis of satura- 
tion curve. The curve is the average of 4 experiments ( tandard evia- 
tion of each point was less than 15% of the mean). 
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Fig. 2. Determination ffree [3H]GMP-PNP released by washing cycles 
after preincubation. After preincubation with 1/zM [3H]GMP- PNP, 
as described in section 2 and in the legend to Fig. 1, membranes were 
centrifuged at 27,000 × g and the radioactivity in the l-ml supernatant 
(S 1) was measured. This procedure was repeated 4 times with additional 
1-ml washings ($2-$5) The figure shows a typical experiment, which 
was replicated three times. 
above), the membranes were also washed three times after preincuba- 
tion before being processed for radioactivity and protein measurement. 
Specific binding was defined as the part of total binding displaced by 
a concentration f non-labeled ligand 104 times the radioligand concen- 
tration. 
2.5. Adenylate cyclase activity 
The conditions used for AC determination were the same as for 
binding assays, except for the inclusion of 0.1% bovine serum albumin 
in the incubation medium. After 15 min of incubation of the membrane 
samples with all other components, cAMP synthesis was started by 
addition of ATP (final concentration 1 mM), and stopped after 1 min 
by boiling the tubes for 3 min. The tubes were centrifuged at 12,000 x g 
for 2 min, and the supernatants were used for measuring cAMP content 
by the protein-binding method [18]. 
2.6. Protein measurement 
Protein was measured according to the method of Lowry [19]. 
3. Results 
Fig. 1A demonstrates how GTP-binding sites in chick tectal 
G proteins becohae saturated by preincubation with [3H]GMP- 
PNP; the specifically bound radioactivity was measured after 
three washings to take advantage of the fact that the binding 
of GMP-PNP is practically irreversible under the experimental 
conditions used in this study (it can be removed, however, by 
further incubation at 37°C). Scatchard analysis of the resulting 
saturation curve (Fig. 1B) revealed a single component, with a 
dissociation constant (Kd) of 210 nM, and a maximal density 
of binding sites (Bmax) of 142 pmol/mg protein. Other readily 
washable GTP-binding sites would not be detected by this pro- 
cedure. To monitor the efficiency of the washing procedure, 
free [3H]GMP-PNP was measured in the successive superna- 
tants. After three washings, free [3H]GMP-PNP released is 
barely detectable (Fig. 2). The effects of preincubation with 
GMP-PNP described below should therefore be interpreted as 
due to presaturation of G protein GTP-binding sites in the 
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Fig. 3. Effects of preincubation with increasing concentrations of non- 
radioactive GMP-PNP on further binding of [3H]GMP-PNP or 
[3H]GDP, and on AC activity. Membranes were preincubated with 
non-radioactive GMP-PNP, at the concentrations indicated, and 
washed 3 times as indicated in section 2. After that, membranes were 
incubated with [3H]GMP-PNP or [3H]GDP-S (600nM), or incubated 
for measuring AC activity. Binding values are given as % of the control 
(preincubated without GMP-PNP). Basal AC activity (no GMP-PNP 
added) was 495 pmol cAMP/mg -min. The figure shows a typical exper- 
iment, which was replicated three times. 
tectal membranes, rather than to the presence of any free GMP- 
PNP in the medium. 
That preincubation with non-radioactive GMP-PNP actu- 
ally blocks G protein GTP-binding sites is shown in Fig. 3, 
where the progressive occupation of this class of GTP-binding 
sites by increasing concentrations of non-radioactive GMP- 
PNP gradually decreases the further binding of either 
[3H]GMP-PNP or [3H]GDP to tectal membranes and stimulates 
AC activity in a strictly parallel fashion. The guanine nucleotide 
binding curves in Fig. 3 furthermore show that some 60% of 
the guanine nucleotide binding sites in the membranes remain 
available under these conditions: these binding sites, not 
blocked by preincubation with non-radioactive GMP-PNP, 
must therefore be unrelated to G proteins. This preparation of 
tectal membranes, with G protein GTP-binding sites specifi- 
cally blocked, is therefore an excellent experimental system to 
characterize other possible GTP-binding sites in tectal mem- 
branes and to check whether the displacement of [3H]KA bind- 
ing by guanine nucleotides takes place at the G protein level or 
elsewhere. Indeed, as seen in Fig. 4, GMP-PNP, GDP-S or 
GMP effectively displace [3H]KA binding, whether or not G 
proteins are presaturated with GMP-PNP. In a similar experi- 
ment (Fig. 5), the saturation of GTP-binding sites in G proteins 
by preincubation with GMP-PNP is clearly shown by the lack 
of stimulatory effect on AC of further addition of GMP-PNP 
to preincubated membranes. It should be noted that only 
GMP-PNP, and not GDP-S and GMP, stimulates AC activity 
in the control (preincubated without GMP-PNP) membrane 
preparations. Therefore, all the guanine nucleotides tested is- 
place [3H]KA binding by acting at sites unrelated to G proteins, 
whereas only GTP-like guanine nucleotides stimulate AC activ- 
ity by interaction with G protein GTP-binding sites. 
4. Discussion 
It has been demonstrated that both GTP and GDP inhibit 
the binding of neurotransmitters to a wide variety of receptors, 
such as dopaminergic [20], adrenergic [21], serotoninergic [22], 
purinergic [23], GABAergic [24], muscarinic [25] and opioid [26] 
receptors. However, in these cases, GMP, cGMP and adenine 
derivatives had no inhibitory effects, nor did guanine nucleo- 
tides modify the binding of the respective antagonists. In con- 
trast, evidence has accumulated that suggests that the inhib- 
itory effects of guanine nucleotides on the binding of glutamate 
and analogs, including antagonists, and on the the responses 
of intact cells to glutamate analogs, have unusual properties 
[5-12]. Studies on the interactions between glutamatergic sys- 
tems and guanine nucleotides have shown that GMP, cGMP 
and guanosine may also inhibit the binding of glutamate or 
related agonists to membrane preparations [5,7,10]; further- 
more, guanine nucleotides inhibit the binding of kainate by 
acting on the external surface in closed vesicle preparations 
[10]. If we now take into account hat GMP, cGMP and gua- 
nosine do not bind to G proteins, that GTP and GDP do not 
cross the cell membrane, and that activation of G proteins does 
not interfere with binding of antagonists, it seems reasonable 
to postulate that the inhibitory effects of guanine nucleotides 
on the binding of glutamate and analogs are exerted by acting 
on sites unrelated to G proteins. 
The binding of guanine nucleotides to G proteins has been 
used as a tool to study the role of these proteins in mediating 
interactions between receptors and cellular effectors [27-30]. 
Pre-incubation with GMP-PNP maintains AC activity maxi- 
mally stimulated, even after extensive washing, suggesting that 
stable GMP-PNP-G protein complexes are formed [31-34]. In 
agreement with this fact, our experiments clearly show that 
preincubation of tectal membrane preparations with GMP- 
PNP, followed by washing, is effective in saturating GTP bind- 
ing sites in G proteins (Fig. 1). Pre-saturation of G protein 
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Fig. 4. Effects of preincubation ftectal membranes with non-radioac- 
tive GMP-PNP on the displacement of [3I-1]KA binding by guanine 
nucleotides. Membranes were prepared, preincubated with or without 
(blank controls, open bars) 10/zM GMP-PNP, washed, and incubated 
with 40 nM [3H]KA, with or without ('Total binding') the displacing 
guanine nucleotides (400/zM), as described insection 2. Data represent 
11 experiments (standard eviation of each point was less than 15% of 
the mean). 
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Fig. 5. Effects of preincubation with non-radioactive GMP-PNP on the 
modulation of AC activity by guanine nucleotides. Membranes were 
prepared, preincubated with or without (blank controls, open bars) 
10 aM GMP-PNP, and washed, as described in section 2. AC activity 
was measured in the absence ('Basal activity') or in the presence of 
10/.tM guanine nucleotides. Data represent 9 experiments ( tandard 
deviation of each point was less than 10% of the mean). All AC activity 
values in samples preincubated with GMP-PNP are nearly identical. Of 
the blank controls only GMP-PNP produced a statistically significant 
increase in AC activity (P < 0.05). 
GTP-binding sites by increasing concentrations of non-radio- 
active GMP-PNP effectively decreased the binding of 
[3H]GMP-PNP or [3H]GDP while simultaneously stimulating 
AC activity (Fig. 3). These results indicate that the decrease in 
GMP-PNP and GDP binding is due to the stable GMP-PNP-G 
protein complexes formed during preincubation. The forma- 
tion of these complexes between GMP-PNP and G proteins is 
further supported by the concomitant s imulation of AC activ- 
ity, which reaches a maximum of stimulation when all G pro- 
tein GTP-binding sites are effectively occupied by GMP-PNP. 
The binding of [3H]GMP-PNP and [3H]GDP measured after 
preincubation with saturating concentrations of non-radioac- 
tive GMP-PNP must therefore occur at site(s) not related to G 
proteins. 
The effects of preincubation with non-radioactive GMP- 
PNP on the displacement of [3H]KA, and on the modulation 
of AC activity by guanine nucleotides, are examined in Figs. 4 
and 5. Preincubation with GMP-PNP maintains AC activity 
maximally stimulated even after exhaustive washings (Fig. 5). 
However, this preincubation with GMP-PNP does not modify 
the ability of the different guanine nucleotides to displace 
[3H]KA binding (Fig. 4). Besides, as previously shown by us 
[10], the effects of guanine nucleotides on AC activity and on 
[3H]KA binding are markedly different. AC activity in control 
membranes (preincubated in the absence of GMP-PNP) was 
stimulated only by GMP-PNP (a GTP-like nucleotide), and AC 
activity in membranes preincubated with GMP-PNP remained 
stimulated even in the absence of guanine nucleotides; in both 
membrane preparations, however, the binding of [3H]KA was 
inhibited by all guanine nucleotides. These results uggest that 
the effects of GTP-like guanine nucleotides on AC activity, and 
of all GTP-, GDP-, and GMP-like nucleotides on [3H]KA bind- 
ing, are mediated by distinct mechanism(s), the AC activity 
being stimulated by GMP-PNP (GTP-like) through G proteins 
and the [3H]KA binding being displaced by GMP-PNP, GDP-S 
and GMP by interaction with a second guanine nucleotide 
binding site, quite possibly the kainate receptor itself. 
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